Vignola Mark J. 4
4 · Terns Pharmaceuticals, Inc. · Filed Jun 8, 2022
Insider Transaction Report
Form 4
Vignola Mark J.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2022-05-31$1.47/sh+7,656$11,254→ 7,656 total
Footnotes (1)
- [F1]Includes the purchase of 7,656 shares under the Terns Employee Stock Purchase Plan on May 31, 2022.